93 related articles for article (PubMed ID: 12426061)
1. Nefiracetam induces a long-lasting facilitation of hippocampal postsynaptic responses in mice lacking the NMDA receptor epsilon1 subunit.
Matsumoto S; Kanno T; Nomura T; Shiotani T; Watabe S; Nabeshima T; Nishizaki T
Brain Res; 2002 Nov; 956(1):178-81. PubMed ID: 12426061
[TBL] [Abstract][Full Text] [Related]
2. A 'long-term-potentiation-like' facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam.
Nishizaki T; Matsuoka T; Nomura T; Matsuyama S; Watabe S; Shiotani T; Yoshii M
Brain Res; 1999 May; 826(2):281-8. PubMed ID: 10224305
[TBL] [Abstract][Full Text] [Related]
3. Attenuated LTP in hippocampal dentate gyrus neurons of mice deficient in the PAF receptor.
Chen C; Magee JC; Marcheselli V; Hardy M; Bazan NG
J Neurophysiol; 2001 Jan; 85(1):384-90. PubMed ID: 11152738
[TBL] [Abstract][Full Text] [Related]
4. The protective action of nefiracetam against electrophysiological and metabolic damage in the hippocampus after deprivation of glucose and oxygen.
Aihara H; Li X; Fujiwara S; Matsumura T; Okumura S; Tozaki H; Kanno T; Ohta K; Nagai K; Nishizaki T
Brain Res; 2001 Dec; 922(1):158-62. PubMed ID: 11730716
[TBL] [Abstract][Full Text] [Related]
5. Xenon attenuates hippocampal long-term potentiation by diminishing synaptic and extrasynaptic N-methyl-D-aspartate receptor currents.
Kratzer S; Mattusch C; Kochs E; Eder M; Haseneder R; Rammes G
Anesthesiology; 2012 Mar; 116(3):673-82. PubMed ID: 22293720
[TBL] [Abstract][Full Text] [Related]
6. Long-term potentiation in direct perforant path projections to the hippocampal CA3 region in vivo.
Do VH; Martinez CO; Martinez JL; Derrick BE
J Neurophysiol; 2002 Feb; 87(2):669-78. PubMed ID: 11826036
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
8. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
9. Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice.
Moriguchi S; Han F; Shioda N; Yamamoto Y; Nakajima T; Nakagawasai O; Tadano T; Yeh JZ; Narahashi T; Fukunaga K
J Neurochem; 2009 Jul; 110(1):170-81. PubMed ID: 19457128
[TBL] [Abstract][Full Text] [Related]
10. Frequency-dependent inhibition in the dentate gyrus is attenuated by the NMDA receptor blocker MK-801 at doses that do not yet affect long-term potentiation.
Rosenblum K; Maroun M; Richter-Levin G
Hippocampus; 1999; 9(5):491-4. PubMed ID: 10560918
[TBL] [Abstract][Full Text] [Related]
11. Synaptic strength at the temporoammonic input to the hippocampal CA1 region in vivo is regulated by NMDA receptors, metabotropic glutamate receptors and voltage-gated calcium channels.
Aksoy-Aksel A; Manahan-Vaughan D
Neuroscience; 2015 Nov; 309():191-9. PubMed ID: 25791230
[TBL] [Abstract][Full Text] [Related]
12. NMDA receptor antagonists block heterosynaptic long-term depression (LTD) but not long-term potentiation (LTP) in the CA3 region following lateral perforant path stimulation.
Kosub KA; Do VH; Derrick BE
Neurosci Lett; 2005 Feb; 374(1):29-34. PubMed ID: 15631891
[TBL] [Abstract][Full Text] [Related]
13. The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors.
Nishizaki T; Nomura T; Matuoka T; Kondoh T; Enikolopov G; Sumikawa K; Watabe S; Shiotani T; Yoshii M
Brain Res Mol Brain Res; 2000 Aug; 80(1):53-62. PubMed ID: 11039729
[TBL] [Abstract][Full Text] [Related]
14. Endogenous neurotrophin-3 regulates short-term plasticity at lateral perforant path-granule cell synapses.
Kokaia M; Asztely F; Olofsdotter K; Sindreu CB; Kullmann DM; Lindvall O
J Neurosci; 1998 Nov; 18(21):8730-9. PubMed ID: 9786980
[TBL] [Abstract][Full Text] [Related]
15. Evidence for involvement of group II/III metabotropic glutamate receptors in NMDA receptor-independent long-term potentiation in area CA1 of rat hippocampus.
Grover LM; Yan C
J Neurophysiol; 1999 Dec; 82(6):2956-69. PubMed ID: 10601432
[TBL] [Abstract][Full Text] [Related]
16. Steroid pregnenolone sulfate enhances NMDA-receptor-independent long-term potentiation at hippocampal CA1 synapses: role for L-type calcium channels and sigma-receptors.
Sabeti J; Nelson TE; Purdy RH; Gruol DL
Hippocampus; 2007; 17(5):349-69. PubMed ID: 17330865
[TBL] [Abstract][Full Text] [Related]
17. Kindling induces transient NMDA receptor-mediated facilitation of high-frequency input in the rat dentate gyrus.
Behr J; Heinemann U; Mody I
J Neurophysiol; 2001 May; 85(5):2195-202. PubMed ID: 11353034
[TBL] [Abstract][Full Text] [Related]
18. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
Schotanus SM; Chergui K
Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
[TBL] [Abstract][Full Text] [Related]
19. Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action.
Nomura T; Nishizaki T
Brain Res; 2000 Jul; 870(1-2):157-62. PubMed ID: 10869513
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological study on Alzheimer's drugs targeting calcium/calmodulin-dependent protein kinase II.
Moriguchi S
J Pharmacol Sci; 2011; 117(1):6-11. PubMed ID: 21821968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
